A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders

Clinical trial NCT02494258 · COMPLETED

Trial details

NCT number: NCT02494258
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Neoplasm Neoplasms Hematologic Malignancies

Start date: 2015-10-22
Primary completion: 2025-04-14
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.